Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors

Clinical trial NCT04780217 · UNKNOWN

Trial details

NCT number: NCT04780217
Sponsor: ImmVira Pharma Co. Ltd
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Hepatocellular Carcinoma Colorectal Cancer NSCLC Ovarian Cancer Endometrial Cancer

Start date: 2021-08-10
Primary completion: 2025-03-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.